Novel breast cancer susceptibility loci under linkage peaks identified in African ancestry consortia
Heather M Ochs-Balcom,Leah Preus,Zhaohui Du,Robert C Elston,Craig C Teerlink,Guochong Jia,Xingyi Guo,Qiuyin Cai,Jirong Long,Jie Ping,Bingshan Li,Daniel O Stram,Xiao-Ou Shu,Maureen Sanderson,Guimin Gao,Thomas Ahearn,Kathryn L Lunetta,Gary Zirpoli,Melissa A Troester,Edward A Ruiz-Narváez,Stephen A Haddad,Jonine Figueroa,Esther M John,Leslie Bernstein,Jennifer J Hu,Regina G Ziegler,Sarah Nyante,Elisa V Bandera,Sue A Ingles,Nicholas Mancuso,Michael F Press,Sandra L Deming,Jorge L Rodriguez-Gil,Song Yao,Temidayo O Ogundiran,Oladosu Ojengbede,Manjeet K Bolla,Joe Dennis,Alison M Dunning,Douglas F Easton,Kyriaki Michailidou,Paul D P Pharoah,Dale P Sandler,Jack A Taylor,Qin Wang,Katie M O’Brien,Clarice R Weinberg,Cari M Kitahara,William Blot,Katherine L Nathanson,Anselm Hennis,Barbara Nemesure,Stefan Ambs,Lara E Sucheston-Campbell,Jeannette T Bensen,Stephen J Chanock,Andrew F Olshan,Christine B Ambrosone,Olufunmilayo I Olopade,David V Conti,Julie Palmer,Montserrat García-Closas,Dezheng Huo,Wei Zheng,Christopher Haiman,the Ghana Breast Health Study Team
DOI: https://doi.org/10.1093/hmg/ddae002
IF: 5.1214
2024-01-25
Human Molecular Genetics
Abstract:Expansion of genome-wide association studies across population groups is needed to improve our understanding of shared and unique genetic contributions to breast cancer. We performed association and replication studies guided by a priori linkage findings from African ancestry (AA) relative pairs. We performed fixed-effect inverse-variance weighted meta-analysis under three significant AA breast cancer linkage peaks (3q26-27, 12q22-23, and 16q21-22) in 9241 AA cases and 10 193 AA controls. We examined associations with overall breast cancer as well as estrogen receptor (ER)-positive and negative subtypes (193,132 SNPs). We replicated associations in the African-ancestry Breast Cancer Genetic Consortium (AABCG). In AA women, we identified two associations on chr12q for overall breast cancer (rs1420647, OR = 1.15, p = 2.50×10 −6 ; rs12322371, OR = 1.14, p = 3.15×10 −6 ), and one for ER-negative breast cancer (rs77006600, OR = 1.67, p = 3.51×10 −6 ). On chr3, we identified two associations with ER-negative disease (rs184090918, OR = 3.70, p = 1.23×10 −5 ; rs76959804, OR = 3.57, p = 1.77×10 −5 ) and on chr16q we identified an association with ER-negative disease (rs34147411, OR = 1.62, p = 8.82×10 −6 ). In the replication study, the chr3 associations were significant and effect sizes were larger (rs184090918, OR: 6.66, 95% CI: 1.43, 31.01; rs76959804, OR: 5.24, 95% CI: 1.70, 16.16). The two chr3 SNPs are upstream to open chromatin ENSR00000710716, a regulatory feature that is actively regulated in mammary tissues, providing evidence that variants in this chr3 region may have a regulatory role in our target organ. Our study provides support for breast cancer variant discovery using prioritization based on linkage evidence.
genetics & heredity,biochemistry & molecular biology